NEW YORK, Nov. 18, 2025 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the inaugural 2025 Prix Galien Bridges Awards nominees for “Best Bridge-Builder Institution,” “Best Biomedical Product,” “Best Medical Technology/AI Advances in Human Health,” “Best Product for Rare/Orphan Diseases,” and “Best Public Sector Innovation.” Winners will be announced during the inaugural Prix Galien Bridges Ceremony on December 5, 2025, at the Nobel Forum, located on the Solna campus of Karolinska Institutet in Stockholm, Sweden.
The Galien Bridges Awards are designed to recognize unique innovation, expertise, and knowledge transfers from the Nordic region, with the addition of five strategic countries – Austria, Israel, The Netherlands, Portugal, and Spain – to form what the Foundation recognizes as the Nordics+ group.
“As Chair of the Prix Galien Bridges Committee, I am honored to celebrate nominees whose work embodies the spirit of collaboration and innovation that defines the Bridges initiative,” said Mikael Dolsten, Board member at Agilent Technologies, Rocket Pharmaceuticals, Chai Discovery, BenchSci, and Enveda Biosciences. “Their groundbreaking contributions reflect the strength of the Nordics+ ecosystem and its partners, advancing scientific progress and forging new pathways to improve health around the world.”